Eric J Hyllengren is EVP, CFO of Atara Biotherapeutics, Inc.. Currently has a direct ownership of 645,671 shares of ATRA, which is worth approximately $5.49 Million. The most recent transaction as insider was on May 16, 2024, when has been sold 28,648 shares (Common Stock) at a price of $0.62 per share, resulting in proceeds of $17,761. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 646K
4.25% 3M change
185.52% 12M change
Total Value Held $5.49 Million

Eric J Hyllengren Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 16 2024
SELL
Open market or private sale
$17,761 $0.62 p/Share
28,648 Reduced 4.25%
645,671 Common Stock
Mar 04 2024
SELL
Open market or private sale
$4,808 $0.72 p/Share
6,679 Reduced 0.98%
674,319 Common Stock
Jan 08 2024
BUY
Grant, award, or other acquisition
-
475,000 Added 41.09%
680,998 Common Stock
Nov 16 2023
SELL
Open market or private sale
$4,663 $0.39 p/Share
11,958 Reduced 5.49%
205,998 Common Stock
Aug 16 2023
SELL
Open market or private sale
$13,506 $1.65 p/Share
8,186 Reduced 3.62%
217,956 Common Stock
May 16 2023
SELL
Open market or private sale
$16,152 $2.04 p/Share
7,918 Reduced 3.38%
226,142 Common Stock
EJH

Eric J Hyllengren

EVP, CFO
Thousand Oaks, CA

Track Institutional and Insider Activities on ATRA

Follow Atara Biotherapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRA shares.

Notify only if

Insider Trading

Get notified when an Atara Biotherapeutics, Inc. insider buys or sells ATRA shares.

Notify only if

News

Receive news related to Atara Biotherapeutics, Inc.

Track Activities on ATRA